0.cached.png
By Newsweek Editors
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
When NEWSWEEK last spoke with Larry Feinberg, who manages a health-care. investment fund at Oracle Partners, it was a scary time for his favorite stocks. Health-care stocks were underwater, largely because Hillary Clinton's task force was writing its proposal to overhaul the nation's medical system. Despite the uncertainty, Feinberg gave some prescient advice: two of his picks, Medeo Containment and American Cyanamid, scored big gains when they were acquired as part of industry-wide consolidation. Now that the Clintons' plan is chilling in the morgue, health-care stocks are on the rise. "People have been selling these stocks for 2 1/2 years," Feinberg says. "Finally they're starting to buy them "His best bets for the upturn:
Coram Healthcare and Homemedco, which benefit from cost-conscious hospitals' rush to get patients home.
Read More on News
Schering-Plough and Upjohn. All signs point to more consolidation, and investors might catch some profits from the merger action.
Chiron and Amgen. "I think Wall Street has thrown in the towel in biotech," he says. "That's when I love to step in and buy."
View 0 Comments
Submit Correction
View Editorial & AI Guidelines